News

CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?
CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
Many US employers plan to pare health benefits as weight-loss spending soars
More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...
Honolulu Star-Advertiser3d
Weight-loss drug costs drive employers to trim health benefits
NEW YORK >> More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from ...
KSL3d
Many employers plan to pare health benefits as weight-loss spending soars
More than half of large employers plan to scale back health care benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new survey released by ...
Tribune Chronicle5d
Prices down for Wegovy and Zepbound
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...
Rocky Mount Telegram6d
Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.